Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus

References

• CostnerMISontheimerRDProvostTTLupus erythematosusSontheimerRDProvostTTCutaneous Manifestations of Rheumatic DiseasesPhiladephiaWilliams & Wilkins20031564
   Google Scholar
• RothfieldNSontheimerRDBernsteinMLupus erythematosus: systemic and cutaneous manifestationsClin Dermatol20062434836216966017
   PubMed Web of Science ®Google Scholar
• KuhnARuzickaTClassification of cutaneous lupus erythematosusKuhnALehmannPRuzickaTCutaneous Lupus ErythematosusHeidelbergSpringer20045358
   Google Scholar
• TebbeBOrfanosCEPrognosis of cutaneous lupus erythematosusKuhnALehmannPRuzickaTCutaneous lupus erythematosusHeidelbergSpringer2004187204
   Google Scholar
• RennerRSticherlingMThe different faces of cutaneous lupus erythematosusG Ital Dermatol Venereol200914413514719357621
   PubMed Web of Science ®Google Scholar
• SticherlingMBonsmannGKuhnADiagnostic approach and treatment of cutaneous lupus erythematosusJ Deutsch Dermatol Ges200864861
   Web of Science ®Google Scholar
• GilliamJNThe cutaneous signs of lupus erythematosusCont Educ Fam Phys197763740
   Google Scholar
• GilliamJNSontheimerRDDistinctive cutaneous subsets in the spectrum of lupus erythematosusJ Am Acad Dermatol198144714757229150
   PubMed Web of Science ®Google Scholar
• ProvostTTNonspecific cutaneous manifestations of systemic lupus erythematosusKuhnALehmannPRuzickaTCutaneous lupus erythematosusHeidelbergSpringer200493106
   Google Scholar
• VasooSDrug-induced lupus: an updateLupus20061575776117153847
   PubMed Web of Science ®Google Scholar
• SontheimerRDHendersonCLGrauRHDrug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigationArch Dermatol Res2009301657018797894
   PubMed Web of Science ®Google Scholar
• MassoneCKodamaKSalmhoferWLupus erythemtaosus panniculitis (lupus profundus): clinical, histopathological and molecular analysis of nine casesJ Cutan Pathol20053239640415953372
   PubMed Web of Science ®Google Scholar
• RequenaLSanchezYEPanniculitis (Part II). Mostly lobular panniculitisJ Am Acad Dermatol20014532536111511831
   PubMed Web of Science ®Google Scholar
• KuhnASticherlingMBonsmannGClinical manifestations of cutaneous lupus erythematosusJ Deutsch Dermatol Ges2007511241140
   PubMedGoogle Scholar
• Lee-KirschMAGongMSchulzHFamilial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3pAm J Hum Genet20067973173716960810
   PubMed Web of Science ®Google Scholar
• RuizHSanchezJLTumid lupus erythematosusAm J Dermatopathol19992135636010446777
   PubMed Web of Science ®Google Scholar
• KuhnABijlMPathogenesis of cutaneous lupus erythematosusLupus20081738939318490414
   PubMed Web of Science ®Google Scholar
• MondCBPetersonMGRothfieldNFCorrelation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patientsArthritis Rheum1989322022042493253
   PubMed Web of Science ®Google Scholar
• UekiHKoebner phenomenon in lupus erythematosus with special consideration of clinical findingsAutoimmun Rev2005421922315893715
   PubMed Web of Science ®Google Scholar
• BaimaBSticherlingMApoptosis in different cutaneous manifestations of lupus erythematosusBr J Dermatol200114495896611359381
   PubMed Web of Science ®Google Scholar
• KuhnABeissertSPhotosensitivity in lupus erythematosusAutoimmunity20053851952916373257
   PubMed Web of Science ®Google Scholar
• KuhnAHerrmannMKleberSAccumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiationArthritis Rheum20065493995016511837
   PubMed Web of Science ®Google Scholar
• CardinaliCCaproniMFabbriPThe composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE)Lupus1999875576010602449
   PubMed Web of Science ®Google Scholar
• GainesEWerthVPDevelopment of outcome measures for autoimmune dermatosesArch Dermatol Res200830013917985101
   PubMed Web of Science ®Google Scholar
• AlbrechtJTaylorLBerlinJAThe CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosusJ Invest Dermatol200512588989416297185
   PubMed Web of Science ®Google Scholar
• Bonilla-MartinezZLAlbrechtJTroxelABThe cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosusArch Dermatol200814417318018283174
   PubMedGoogle Scholar
• KuhnAKuehnEMeuthAMDevelopment of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)Autoimmun Rev2009870271219232553
   PubMed Web of Science ®Google Scholar
• TingWWSontheimerRDLocal therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerationsLupus20011017118411315348
   PubMed Web of Science ®Google Scholar
• LehmannPTopical treatment of cutaneous lupus erythematosusKuhnALehmannPRuzickaTCutaneous lupus erythematosusHeidelbergSpringer2005337345
   Google Scholar
• ErmannJBermasBLThe biology behind the new therapies for SLEInt J Clin Pract2007612113211917997810
   PubMed Web of Science ®Google Scholar
• ReinholdUButtgereitFHigh dosage steroid pulse therapy. Is there an indication in dermatology?Hautarzt20005173874511153359
   PubMed Web of Science ®Google Scholar
• MarmorMFCarrREEasterbrookMRecommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of OphthalmologyOphthalmology20021091377138212093666
   PubMed Web of Science ®Google Scholar
• OchsendorfFRAntimalarialsKuhnALehmannPRuzickaTCutaneous lupus erythematosusHeidelbergSpringer2004347372
   Google Scholar
• Costedoat-ChalumeauNAmouraZHulotJSHydroxy-chloroquine in systemic lupus erythematosusLancet200736995691257125817434394
   PubMed Web of Science ®Google Scholar
• BöhmIBrunsASchuppGANCA-positive lupus erythematodes profundus. Successful therapy with low dosage dapsoneHautarzt1998494034079642563
   PubMed Web of Science ®Google Scholar
• BöhmIWenzelJFACS monitoring of lymphocyte-subsets in patients with discoid and subacute-cutaneous lupus erythematosus receiving low-dose methotrexateScan J Rheumatol200231216220
   Web of Science ®Google Scholar
• SchanzSUlmerARassnerGSuccessful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetilBr J Dermatol200214717417812100205
   PubMed Web of Science ®Google Scholar
• GoyalSNousariHCTreatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetilJ Am Acad Dermatol20014514214411423853
   PubMed Web of Science ®Google Scholar
• TuYPengXWangLMMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study GroupA prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritisLupus20081762262918625634
   PubMed Web of Science ®Google Scholar
• BoehnckeWHOchsendorfFPaeslackIDecorative cosmetics improve the qualitiy of life in patients with disfiguring skin diseasesEur J Dermatol20021257758012459532
   PubMed Web of Science ®Google Scholar
• LugerTPaulCPotential new indications of topical calcineurin inhibitorsDermatology2007215Suppl 1455418174692
   PubMed Web of Science ®Google Scholar
• HoSClipstoneNTimmermannLThe mechanism of action of cyclosporin A and FK506Clin Immunol Immunopathol199680S40S458811062
   PubMedGoogle Scholar
• WollinaUHanselGThe use of topical calcineurin inhibitors in lupus erythematosus: an overviewJ Eur Acad Dermatol Venereol2008221618005117
   PubMed Web of Science ®Google Scholar
• GuptaAKChowMPimecrolimus: a reviewJ Eur Acad Dermatol Venereol20031749350312941081
   PubMed Web of Science ®Google Scholar
• GotoTNakagawaHDevelopment of tacrolimus ointmentRuzickaTReitamoSTacrolimus Ointment A topical immunomodulator for atopic dermatitisHeidelbergSpringer20048198
   Google Scholar
• WollenbergAReitamoSAtzoriFProactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointmentAllergy200863742750
   Web of Science ®Google Scholar
• WooDKJamesWDTopical tacrolimus: a review of its uses in dermatologyDermatitis20051662115996345
   PubMed Web of Science ®Google Scholar
• De ProstYClinical experience in childrenRuzickaTReitamoSTacrolimus Ointment A topical immunomodulator for atopic dermatitisHeidelbergSpringer2004161183
   Google Scholar
• ReitamoSClinical experience in adultsRuzickaTReitamoSTacrolimus Ointment A topical immunomodulator for atopic dermatitisHeidelbergSpringer2004129160
   Google Scholar
• RingJAbrahamAde CuyperCControl of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a >2000 patient studyJ Eur Acad Dermatol Venereol20082219520318211413
   PubMed Web of Science ®Google Scholar
• DissemondJGoosMWagnerSNPimecrolimus (SDZ ASM 981). Current state of researchDtsch Med Wochenschr20021271199120312035117
   PubMed Web of Science ®Google Scholar
• HoetzeneckerWEckerRKoppTPimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitisJ Allergy Clin Immunol20051151276128315940147
   PubMed Web of Science ®Google Scholar
• HoetzeneckerWMeingassnerJGEckerRCorticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cellsJ Invest Dermatol200412267368415086553
   PubMed Web of Science ®Google Scholar
• MeingassnerJGKowalskyESchwendingerHPimecrolimus does not affect Langerhans cells in murine epidermisBr J Dermatol200314985385714616380
   PubMed Web of Science ®Google Scholar
• Queille-RousselCPaulCDuteilLThe new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled studyBr J Dermatol200114450751311260007
   PubMed Web of Science ®Google Scholar
• DraelosZDUse of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areasCurr Med Res Opin20082498599418284804
   PubMed Web of Science ®Google Scholar
• BillichAAschauerHAszodiAPercutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimusInt J Pharm2004269293514698574
   PubMed Web of Science ®Google Scholar
• WooltortonEEczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concernsCMAJ20051721179118015817641
   PubMed Web of Science ®Google Scholar
• SárdyMRuzickaTKuhnATopical calcineurin inhibitors in cutaneous lupus erythematosusArch Dermatol Res2009301939818797893
   PubMed Web of Science ®Google Scholar
• WalkerSLKirbyBChalmersRJThe effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosusBr J Dermatol200214740540612174136
   PubMed Web of Science ®Google Scholar
• YoshimasuTOhtaniTSakamotoTTopical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositisEur J Dermatol200212505211809595
   PubMed Web of Science ®Google Scholar
• BöhmMGaubitzMLugerTATopical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three casesDermatology200320738138514657631
   PubMed Web of Science ®Google Scholar
• BacmanDTanbajewaAMegahedMTopical treatment with tacrolimus in lupus erythematosus tumidusHautarzt20035497797914513247
   PubMed Web of Science ®Google Scholar
• KanekuraTYoshiiNTerasakiKEfficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosusBr J Dermatol200314835335612588393
   PubMed Web of Science ®Google Scholar
• De la Rosa CarrilloDChristensenOBTreatment of chronic discoid lupus erythematosus with topical tacrolimusActa Derm Venereol200484323323415202845
   PubMed Web of Science ®Google Scholar
• DrükeAGambichlerTAltmeyerP0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosusJ Dermatolog Treat200415636414754655
   PubMedGoogle Scholar
• LampropoulosCESangleSHarrisonPTopical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternativeRheumatology2004431383138515266063
   PubMed Web of Science ®Google Scholar
• MellerSBruch-GerharzDRuzickaTTopische Behandlung des subakut-kutanen Lupus erythematodes mit TacrolimusHautarzt20055636836915750673
   PubMed Web of Science ®Google Scholar
• HeffernanMPNelsonMMSmithDI0.1% tacrolimus ointment in the treatment of discoid lupus erythematosusArch Dermatol20051411170117116172325
   PubMedGoogle Scholar
• SuganoMShintaniYKobayashiKSuccessful treatment with topical tacrolimus in four cases of discoid lupus erythematosusJ Dermatol20063388789117169097
   PubMed Web of Science ®Google Scholar
• Von PelchrzimRSchmookTFriedrichMEfficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosusInt J Dermatol200645848516426386
   PubMed Web of Science ®Google Scholar
• TzungTYLiuYSChangHWTacrolimus vs clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison studyBr J Dermatol200715619119217199600
   PubMed Web of Science ®Google Scholar
• CooperRMButlerDFGhaliFPeriorbital cutaneous neonatal lupusSkinmed20076314514617483660
   PubMedGoogle Scholar
• MadanVAugustPJChalmersRJEfficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort studyClin Exp Dermatol201035273019549244
   PubMed Web of Science ®Google Scholar
• KawachiYTaguchiSFujisawaYFurutaJNakamuraYIshiiYOtsukaFLinear Childhood Discoid Lupus Erythematosus Following the Lines of Blaschko: Successfully Treated with Topical TacrolimusPediatr Dermatol201091 [Epub ahead of print]
   Google Scholar
• HanYWKimHOParkSHParkYMFour cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimusAnn Dermatol20102230731120711267
   PubMed Web of Science ®Google Scholar
• ZabawskiETreatment of cutaneous lupus with ElidelDermatol Online J2002822512546779
   PubMedGoogle Scholar
• KreuterAGambichlerTBreuckmannFPimecrolimus 1% cream for cutaneous lupus erythematosusJ Am Acad Dermatol20045140741015337984
   PubMed Web of Science ®Google Scholar
• Tlacuilo-ParraAGuevara-GutiérrezEGutiérrez-MurilloFPimecrolimus 1% cream for the treatment of discoid lupus erythematosusRheumatology2005441564156816159951
   PubMed Web of Science ®Google Scholar
• SticherlingMGelbrichGRogalskiCTopical pimecrolimus for cutaneous lupus erythematosus – results of a double-blind, placebo controlled studyJ Deutsch Dermatol Ges20075S188S1889
   Google Scholar
• BarikbinBGivradSYousefiMPimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot studyClin Exp Dermatol20093477678019456797
   PubMed Web of Science ®Google Scholar
• Dé TranQHGuayEChartierSTousignantJTacrolimus in dermatologyJ Cutan Med Surg2001532933511907845
   PubMed Web of Science ®Google Scholar
• GrafJWebbADavisJThe use of topical tacrolimus (FK506/Protopic) in cutaneous manifestations of autoimmune diseasesJ Clin Rheumatol2003931031517041481
   PubMed Web of Science ®Google Scholar
• GisondiPEllisCNGirolomoniGPimecrolimus in dermatology: atopic dermatitis and beyondInt J Clin Pract20055996997416033622
   PubMed Web of Science ®Google Scholar
• LinANInnovative use of topical calcineurin inhibitorsDermatol Clin20102853554520510763
   PubMed Web of Science ®Google Scholar
• TzellosTGKouvelasDTopical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluationEur J Clin Pharmacol20086433734118157526
   PubMed Web of Science ®Google Scholar
• MerrillJTTopical tacrolimus and pimecrolimus for cutaneous lupusCurr Rheumatol Rep200810263264
   Google Scholar
• JessopSWhitelawDADelamereFMDrugs for discoid lupus erythematosusCochrane Database Syst Rev20091074CD00295419821298
   PubMed Web of Science ®Google Scholar
• BrenemanDFleischerABJrAbramovitsWIntermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicleJ Am Acad Dermatol20085899099918359127
   PubMed Web of Science ®Google Scholar
• RingJMöhrenschlagerMHenkelVThe US FDA ‘black box’ warning for topical calcineurin inhibitors: an ongoing controversyDrug Saf20083118519818302444
   PubMed Web of Science ®Google Scholar